Pursuant to Section 13 or 15(d) of The Securities Act of 1934
| Date of Report (Date of earliest event reported): | September 2, 2005 |
| MERIDIAN BIOSCIENCE, INC. |
|---|
| (Exact name of Registrant as specified in its Charter) |
| Ohio | 0-14902 | 31-0888197 |
|---|---|---|
| (State or Other Jurisdiction of Incorporation) |
(Commission File Number) | (IRS Employer Identification No.) |
| 3471 River Hills Drive, Cincinnati, Ohio | 45244 |
|---|---|
| (Address of Principal Executive Offices) | (Zip Code) |
| Registrant's telephone number, including area code | (513) 271-3700 |
(Former name or former
address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| [ ] | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| [ ] | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| [ ] | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| [ ] | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
On August 15, 2005, Meridian Bioscience, Inc. (the “Company”) announced that its Board of Directors had approved a 3-for-2 stock split of the Company’s outstanding shares of common stock (the “Common Stock”) effective September 2, 2005, for shareholders of record on August 29, 2005 (the “Stock Split”).
The Company is undertaking to meet the requirements of Rule 416(b) under the Securities Act of 1933, as amended, regarding its Registration Statement No. 333-109139 (the “Registration Statement”). Under Rule 416(b), if additional securities are issued as a result of a stock split prior to the completion of the distribution of the securities covered by a registration statement, then the additional securities are covered by the registration statement, provided that the registration statement is amended. As discussed, the Company has effected the Stock Split. Pursuant to Rule 416(b), by virtue of this filing, the Registration Statement is deemed to cover the additional shares of common stock that may be sold as a result of the Stock Split.
In addition, the following tables present, adjusted to reflect the stock split, the Selected Financial Data from the Company’s Annual Report on Form 10-K for the year ended September 30, 2004 and earnings per share information for the interim periods in fiscal 2005:
Selected Financial Data –
Annual Report on Form 10-K for the Fiscal Year Ended September 30, 2004
Amounts in
thousands, except for per share data
| FY 2004 |
FY 2003 |
FY 2002 |
FY 2001 |
FY 2000 |
FY 1999 | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales | $ | 79,606 | $ | 65,864 | $ | 59,104 | $ | 56,527 | $ | 57,096 | $ | 53,927 | ||||||||
| Gross profit | 45,675 | 38,288 | 34,598 | 26,706 | 35,446 | 34,369 | ||||||||||||||
| Operating income (loss) | 14,658 | 12,789 | 9,994 | (12,507 | ) | 9,354 | 6,527 | |||||||||||||
| Net earnings (loss) | 9,185 | 7,018 | 5,031 | (10,275 | ) | 7,111 | 2,073 | |||||||||||||
| Basic earnings (loss) per share | $ | 0.41 | $ | 0.32 | $ | 0.23 | $ | (0.47 | ) | $ | 0.33 | $ | 0.10 | |||||||
| Diluted earnings (loss) per share | $ | 0.40 | $ | 0.31 | $ | 0.23 | $ | (0.47 | ) | $ | 0.32 | $ | 0.09 | |||||||
| Cash dividends declared per share | $ | 0.26 | $ | 0.23 | $ | 0.18 | $ | 0.17 | $ | 0.15 | $ | 0.13 | ||||||||
| Book value per share | $ | 1.47 | $ | 1.24 | $ | 1.11 | $ | 1.05 | $ | 1.67 | $ | 1.55 | ||||||||
| 30-Sep-04 |
30-Sep-03 |
30-Sep-02 |
30-Sep-01 |
30-Sep-00 |
30-Sep-99 | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current assets | $ | 36,111 | $ | 32,561 | $ | 30,375 | $ | 32,502 | $ | 40,798 | $ | 31,744 | ||||||||
| Current liabilities | 16,650 | 15,330 | 15,249 | 16,368 | 16,619 | 13,602 | ||||||||||||||
| Total assets | 69,322 | 66,420 | 65,095 | 65,982 | 84,717 | 72,161 | ||||||||||||||
| Long-term debt obligations | 17,093 | 21,505 | 23,626 | 24,349 | 27,159 | 22,187 | ||||||||||||||
| Shareholders' equity | 32,932 | 27,484 | 24,381 | 22,944 | 36,611 | 33,591 | ||||||||||||||
Earnings Per Share and Cash Dividends Per Share Information – Interim Periods FY 2005
| Three Months Ended |
|||||||||
|---|---|---|---|---|---|---|---|---|---|
| December 31, 2004 |
December 31, 2003 |
||||||||
| Basic EPS | $0.09 | $0.08 | |||||||
| Diluted EPS | $0.09 | $0.08 | |||||||
| Cash Dividends | $0.07 | $0.06 | |||||||
| Three Months Ended |
Six Months Ended | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| March 31, 2005 |
March 31, 2004 |
March 31, 2005 |
March 31, 2004 | ||||||
| Basic EPS | $0.14 | $0.10 | $0.23 | $0.18 | |||||
| Diluted EPS | $0.13 | $0.10 | $0.22 | $0.18 | |||||
| Cash Dividends | $0.08 | $0.07 | $0.15 | $0.13 | |||||
| Three Months Ended |
Nine Months Ended | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| June 30, 2005 |
June 30, 2004 |
June 30, 2005 |
June 30, 2004 | ||||||
| Basic EPS | $0.15 | $0.10 | $0.38 | $0.28 | |||||
| Diluted EPS | $0.14 | $0.09 | $0.37 | $0.27 | |||||
| Cash Dividends | $0.08 | $0.07 | $0.23 | $0.19 | |||||
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: September 9, 2005 |
MERIDIAN BIOSCIENCE, INC. BY: /s/ Melissa Lueke —————————————— Melissa Lueke Vice President and Chief Financial Officer (Principal Accounting Officer) |